rss
Evid Based Med 5:14 doi:10.1136/ebm.5.1.14
  • Therapeutics

Atorvastatin was at least as effective as PTCA for reducing ischaemic events in patients with stable coronary artery disease

Atorvastatin v percutaneous transluminal coronary angioplasty (PTCA) plus usual care for patients with stable coronary artery disease†

Outcome at 18 months Atorvastatin PTCA RRR (95% CI) NNT (CI)
†Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article.
Any ischaemic event 13.4% 20.1% 35.8% (−3 to 60) Not significant

This Article

Latest from the blog

Latest from the blog


Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.